BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Quick Info:
Status:
Currently Recruiting
Estimated Enrollment:
15
Phase:
Treatment Type:
Device
Trial Type:
Open Label
Sponsor:
Leigh R. Hochberg, MD, PhD., Massachusetts General Hospital
Primary Investigator:
Leigh R Hochberg, M.D., Ph.D.
Contact Information:
Trial Goal:
  • Devices
    Brain-machine interfaces and other devices to improve QoL of PALS
  • Tests to Expect:
Update Notes:
3/28/2014Recruitment locations updated.
2/22/2013
Locations: (Available Locations: 4) Recruiting?
United States, MA, Boston, Massachusetts General HospitalYES
United States, CA, Stanford, Stanford University School of MedicineYES
United States, OH, Cleveland, Case Western Reserve UniversityYES
United States, RI, Providence, Providence VA Medical CenterYES
Other Information:
Purpose: The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility of efficacy) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Eligibility: 18 years to 75 years. Both genders. No healthy volunteers.
Details: The goal of the BrainGate2 research and development project is to identify the core methods and features for a medical device that could allow people with paralysis to recover a host of abilities that normally rely on the hands.
Collaborator(s):
ALS Forum:
First Published on Clinicaltrials.gov: 6/1/2009
ClinicalTrials.gov ID: NCT00912041
Trial Protocol as Published on Clinicaltrials.gov:
ClinicalTrials.gov